ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Indiana » Internal Medicine

Top Internal Medicine Prescribers in Indiana

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHERIE BENNETT M.D.

Internal Medicine

13,628

$612K

430
399 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $61

DAVID KAY M.D.

Internal Medicine

13,502

$719K

695
614 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$53
Average prescription price

Avg: $61

KAY LOWNEY MD

Internal Medicine

13,495

$777K

327
280 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$58
Average prescription price

Avg: $61

JAMES BEITZEL MD

Internal Medicine

13,468

$740K

834
628 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

16%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

MINNIE ENRIQUEZ M.D.

Internal Medicine

13,464

$803K

542
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

CRISTINA BICKFORD MD

Internal Medicine

13,365

$793K

599
410 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

MARC CAMPBELL MD

Internal Medicine

13,330

$661K

534
491 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

MONICA BRUNELLE MD

Internal Medicine

13,268

$725K

345
296 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

25%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$55
Average prescription price

Avg: $61

JOHNNY BEAR M.D.

Internal Medicine

13,139

$551K

463
384 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

23%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 25%

$42
Average prescription price

Avg: $61

PURNENDU DATTA MD

Internal Medicine

13,128

$588K

516
402 are 65+

5%
patients receiving schedule two controlled substances

Avg: 6%

28%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 25%

$45
Average prescription price

Avg: $61

STINA WEDLOCK MD

Internal Medicine

13,107

$782K

573
402 are 65+

4%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

RAMESH PATEL M.D.

Internal Medicine

13,100

$563K

364
309 are 65+

9%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$43
Average prescription price

Avg: $61

JOHN TUTTLE M.D.

Internal Medicine

13,029

$774K

408
346 are 65+

10%
patients receiving schedule two controlled substances

Avg: 6%

21%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$59
Average prescription price

Avg: $61

JOSEPH KOSS MD

Internal Medicine

12,913

$975K

387
348 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

13%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 25%

$75
Average prescription price

Avg: $61

RUPESH SHAH DO

Internal Medicine

12,901

$736K

410
349 are 65+

0%
patients receiving schedule two controlled substances

Avg: 6%

17%
patients receiving schedule three controlled substances

Avg: 16%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

KENT FARNSWORTH M.D.

Internal Medicine

12,871

$929K

697
617 are 65+

3%
patients receiving schedule two controlled substances

Avg: 6%

11%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$72
Average prescription price

Avg: $61

VIJAY KAMINENI M.D.

Internal Medicine

12,802

$883K

439
329 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

19%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$69
Average prescription price

Avg: $61

CAROLYN HUDSON M.D.

Internal Medicine

12,781

$779K

537
449 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

7%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

ERIC BANNEC MD

Internal Medicine

12,745

$726K

619
528 are 65+

2%
patients receiving schedule two controlled substances

Avg: 6%

12%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 25%

$57
Average prescription price

Avg: $61

CHRISTOPHER STEINMETZ MD

Internal Medicine

12,721

$687K

1019
446 are 65+

29%
patients receiving schedule two controlled substances

Avg: 6%

29%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$54
Average prescription price

Avg: $61

HOJJAT SHAMLOO MD

Internal Medicine

12,695

$770K

412
280 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

31%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

28%
prescriptions for brand name drugs

Avg: 25%

$61
Average prescription price

Avg: $61

JON STOCKRAHM D.O.

Internal Medicine

12,607

$629K

439
392 are 65+

12%
patients receiving schedule two controlled substances

Avg: 6%

22%
patients receiving schedule three controlled substances

Avg: 16%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

JAMES ONG M.D.

Internal Medicine

12,460

$801K

393
247 are 65+

6%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 25%

$64
Average prescription price

Avg: $61

GERRY HIPPENSTEEL M.D.

Internal Medicine

12,390

$620K

437
381 are 65+

7%
patients receiving schedule two controlled substances

Avg: 6%

20%
patients receiving schedule three controlled substances

Avg: 16%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 25%

$50
Average prescription price

Avg: $61

ROBERT CATER MD

Internal Medicine

12,358

$736K

352
221 are 65+

11%
patients receiving schedule two controlled substances

Avg: 6%

38%
patients receiving schedule three controlled substances

Avg: 16%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 25%

$60
Average prescription price

Avg: $61

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank